Webinars & Videos
Featured
In the first webinar of NFXF’s 2026 Webinar Series, we hear updates from each of the current NIH-funded Fragile X Centers of Excellence. This funding remains critical to sustaining progress and advancing future discoveries.
Latest
Guidelines with relevant resources for families with young children with FXS that are aligned with national early childhood special education and early intervention best practices.
Lauren Moskowitz covers how to assess the functions of challenging behavior (why the behavior is occurring) by first identifying the antecedents that “trigger” it and the consequences that follow it.
All Webinars and Videos
How Fragile X syndrome is inherited is a very common question and one of the first things a newly diagnosed family asks. Let’s be clear — Fragile X is an inherited condition.
Dres. Wilmar Saldarriaga Gil y Ana María Cabal se unen a Johana LaTorre, Judith García, Nelsy Garzón, María Vera, Carolina Rabazani y Facundo Mattea para discutir la genética y las características clínicas del síndrome de X frágil.
Genetic counselor Susan Howell explains how to help self-advocates and siblings understand genetic results, associated reproductive implications, and the landscape of reproductive options. This session aims to help self-advocates and siblings understand genetic results, associated reproductive implications, and the landscape of reproductive options.
A panel of genetics professionals covers a wide range of topics, highlighting the complexity of Fragile X genetics and emphasizing the critical role of a genetic counselor as part of your healthcare team, providing valuable guidance throughout the entire process.
With the possibility of gene therapy getting closer and closer, many researchers are interested in knowing where the Fragile X community stands on the topic; what are the thoughts, feelings, knowledge, concerns, and hopes that come with gene therapy?
The NFXF held its first gene therapy panel discussion at the 19th NFXF International Fragile X Conference. While gene therapy looks to be a promising avenue for future FXS treatment, there is still a lot to learn and a long road ahead.
Brenda Finucane, a professor and licensed genetic counselor at Geisinger’s Autism and Developmental Medicine Institute, guides us through the complexities of the genetics behind Fragile X disorders.
Even for genetics professionals, FMR1 inheritance is complex and confusing, so it’s no surprise that families often have questions about the genetics of Fragile X. Whether you’re a newly diagnosed family in the Fragile X community or have been living with the diagnosis for several years, please join us as we speak with Geisinger professor Brenda Finucane about the nuts and bolts of Fragile X inheritance.